SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 71 filers reported holding SILENCE THERAPEUTICS PLC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,312,233 | $7,217,282 | 4.00% |
| M28 Capital Management LP | 363,800 | $2,000,900 | 2.64% |
| TCG Crossover Management, LLC | 2,104,875 | $11,576,813 | 1.90% |
| Lombard Odier Asset Management (Europe) Ltd | 3,415,360 | $18,784,480 | 0.88% |
| Deep Track Capital, LP | 1,951,580 | $10,733,690 | 0.50% |
| Lombard Odier Asset Management (USA) Corp | 4,120,416 | $18,668,445 | 0.40% |
| Artal Group S.A. | 1,700,000 | $9,350 | 0.29% |
| Frazier Life Sciences Management, L.P. | 881,173 | $4,846,452 | 0.29% |
| BVF INC/IL | 1,508,416 | $8,296,288 | 0.23% |
| Parkman Healthcare Partners LLC | 185,078 | $1,017,929 | 0.18% |